Pembrolizumab as First-line Therapy in Cisplatin-ineligible Advanced Urothelial Cancer (KEYNOTE-052): Outcomes in Older Patients by Age and Performance Status

  1. Grivas, P.
  2. Plimack, E.R.
  3. Balar, A.V.
  4. Castellano, D.
  5. O'Donnell, P.H.
  6. Bellmunt, J.
  7. Powles, T.
  8. Hahn, N.M.
  9. de Wit, R.
  10. Bajorin, D.F.
  11. Ellison, M.C.
  12. Frenkl, T.L.
  13. Godwin, J.L.
  14. Vuky, J.
Revue:
European urology oncology

ISSN: 2588-9311

Année de publication: 2020

Volumen: 3

Número: 3

Pages: 351-359

Type: Article

DOI: 10.1016/J.EUO.2020.02.009 GOOGLE SCHOLAR lock_openAccès ouvert editor
La source de données: Scopus